Utah Medical talks back
This article was originally published in The Gray Sheet
Executive Summary
FDA's public statements "have diminished the company's business through innuendo," by suggesting the firm's alleged QSR non-compliance impacts device safety and effectiveness, Utah Medical charges Aug. 30 in response to an Aug. 9 injunction suit (1"The Gray Sheet" Aug. 16, 2004, p. 6). The manufacturer denies the allegations, which date to 2001. FDA's actions have led competitors to wrongly suggest to customers the firm may be shut down, Utah Medical says. The firm concedes its "total dollar value of orders has remained about normal" in August, but adds that its own 10% customer loyalty discount, instituted Aug. 20, "may have a significant effect on net sales." Utah Medical repurchased about $3.1 mil. of stock between Aug. 1 and Aug. 17...
You may also be interested in...
Utah Medical Upholds Product Safety, Questions FDA Inspector Credentials
Utah Medical Products will challenge during pre-trial discovery whether FDA's inspectional observations of the Midvale, Utah facility can be construed as QSR violations
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.